Metropolis Healthcare Launches TruHealth Cancer Screen 360, a First-of-its-kind Initiative to Strengthen Preventive Oncology in India
A first-of-its-kind in the Indian diagnostics space, the TruHealth Cancer Screen 360 Male and Female Profiles are scientifically curated to provide early insights, equipping both clinicians and individuals with critical, actionable information. This launch reinforces Metropolis' commitment to enhancing access to specialized cancer diagnostics while making them more affordable and inclusive.
Metropolis Healthcare Launches TruHealth Cancer Screen 360, a First-of-its-kind Initiative to Strengthen Preventive Oncology in India
According to the Global Cancer Observatory (GLOBOCAN) 2022, cancer remains a major global health concern. In the South-East Asia region, India ranks third in terms of cancer incidence, second for mortality, and 121st in terms of crude rates globally. Alarmingly, screening coverage in India-especially among women-remains under 1% for cervical, breast, and oral cancers, far below the World Health Organizations 70% target for cervical cancer screening. Limited access to healthcare, low awareness, and financial constraints continue to hinder the adoption of widespread screening.
The TruHealth Cancer Screen 360 includes tumor markers, hereditary cancer risk analysis, and gender-specific screening modules-such as PSA for prostate cancer in men and HPV self-sampling for cervical cancer in women. Designed to address the rising cancer burden and bridge diagnostic gaps, the panel offers a multi-layered, evidence-based approach to detect early signs of common cancers in both men and women.
Commenting on the launch, Mr. Surendran Chemmenkottil, CEO, Metropolis Healthcare Ltd., said, 'The introduction of TruHealth Cancer Screen 360 Male and Female Profiles reflects our unwavering commitment to strengthening preventive healthcare in India. By equipping individuals with timely and reliable diagnostic tools, we aim to empower them to take charge of their health. Early detection is key to reducing the burden of late-stage cancer, improving outcomes, and saving lives. This initiative is also aligned with our strategic focus on expanding Metropolis' footprint in oncology diagnostics-an increasingly critical domain in healthcare. We remain committed to making advanced diagnostics accessible and affordable across both urban and non-urban areas.'
A recent GLOBOCAN report also highlights a concerning trend-earlier onset of cancers in urban populations, with rising incidence of breast, cervical, and ovarian cancers in women, and lung and prostate cancers in men. These often go undiagnosed until advanced stages, making treatment more difficult and outcomes less favourable.
Dr. Kirti Chadha, Senior Oncopathologist and Chief Scientific and Innovation Officer, Metropolis Healthcare Ltd. said, 'With the growing incidence of gender-specific cancers such as breast, cervical, and prostate, there is an urgent need to integrate targeted cancer screening into routine health check-ups. The TruHealth Cancer Screen 360 has been developed as an evidence-based, comprehensive tool that goes beyond general wellness testing. By incorporating a broad spectrum of biomarkers and hereditary risk indicators, it facilitates early identification of cancer risks-even before symptoms appear. This approach enhances clinical decision-making and provides individuals with actionable insights, helping bridge the gap between symptomless disease progression and timely medical intervention.'
Key features of TruHealth Cancer Screen 360 (Male & Female Profiles)
Gender-specific panels for breast, ovarian, cervical, liver, lung, prostate, colorectal, and thyroid cancers.
Three-layered screening combining tumor markers, hereditary cancer risk analysis (covering 25+ cancer types), and organ-specific assessments.
Hereditary cancer screening through a NextGen Panel that analyses 317 genes, enabling preventive measures for patients and family members.
HPV Self-Sampling (Female Profile): WHO-recommended self-test kits for primary cervical cancer screening-removing barriers like discomfort, time constraints, or clinic access.
Free genetic counseling with certified counsellors to support individuals in understanding results and next steps.
The TruHealth Cancer Screen 360 is available at an introductory price, significantly lower than the combined cost of individual tests-making this advanced screening solution both affordable and accessible. With a robust portfolio of over 4,000 tests and profiles, Metropolis continues to lead diagnostic innovation. Through this integrated cancer screening initiative, the company reaffirms its mission to drive early diagnosis, clinical excellence, and preventive healthcare for all.
About Metropolis Healthcare Limited
Established in 1981, Metropolis Healthcare Limited is India's second-largest diagnostic chain, led by visionary leader Ms. Ameera Shah. With over four decades of excellence, Metropolis has been a pioneer in delivering best-in-class diagnostic services to patients, healthcare providers, and corporates across India and Africa. The company's extensive footprint spans 22 states, 3 Union Territories, and over 750 towns in India, supported by a robust network of more than 210 laboratories, 4,500 patient service centers, and over 10,000 touchpoints. Each year, Metropolis serves millions of individuals by providing actionable health insights that empower better clinical outcomes. Metropolis offers a comprehensive range of more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. The company's commitment to quality and accuracy is reinforced by its consistent CAP proficiency score of over 98% for the past decade, placing it among the top 1% of laboratories worldwide for quality assurance. The Metropolis philosophy is built on the pillars of technological superiority, a warm, patient-centric approach, and reliable diagnostic reports.
For more information, please visit www.metropolisindia.com or click on Twitter, Facebook, or LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
39 minutes ago
- News18
Curious About Rishabh Pant's Moon Boots? Here's What They Are And Why He Needs Them
Last Updated: Cricket shoes are lightweight, flexible, and feature spikes to provide traction on the pitch. They are designed for quick movements. Moon boots are rigid and heavy Indian cricket star Rishabh Pant is known for his fearless batting and fiery presence on the field. But off the field, he's showing the same fighting spirit—this time, against injury. After suffering a painful foot injury during the recent Manchester Test against England, Pant has turned heads not just for his resilience, but also for the unique medical shoe he's now wearing: a moon boot. On July 23, 2025, during Day 1 of the fourth Test at Old Trafford, Manchester, Pant was batting fluently on 37 off 48 balls when disaster struck. In an attempt to play a reverse sweep against pacer Chris Woakes, the ball slammed into his right foot. The impact caused immediate swelling and bleeding. Medical staff rushed in, and Pant was taken off the field via a medical cart, visibly in pain. In the days that followed, images of Pant wearing a bulky, futuristic-looking boot went viral. That was not a regular cricket shoe—it was a moonboot, a medical device often used to aid recovery from foot or ankle fractures. What Is A Moon Boot? This specially designed boot serves three critical purposes: Made with a hard plastic shell, thick padding, and Velcro straps, moon boots are sturdy yet surprisingly lightweight. Pant, diagnosed with a metatarsal fracture, has been advised by the BCCI medical team to wear one for a minimum of six weeks. How Much Does A Moon boot Cost? The price of a moon boot in India ranges from Rs 3,000 to Rs 8,000 for standard models. However, top-end brands used in elite sports recovery—like Ossur or DJO Global—can go up to Rs 10,000 or more. As a centrally contracted player, Pant likely received a premium-grade boot tailored for his recovery needs. Moon boot vs Cricket Shoe: What's The Difference? Cricket shoes are lightweight, flexible, and feature spikes to provide traction on the pitch. They are designed for quick movements—running, wicket-keeping, or bowling. Moon boots, on the other hand, are rigid and heavy. They are not made for performance but for protection and healing. There are no spikes, and they restrict movement intentionally. Pant's Recovery Timeline According to a BCCI update on July 24, Pant has been advised six weeks of rest and physiotherapy. He will wear the moon boot throughout this period. If his recovery progresses well, light training could begin by September, with a potential full return to competitive cricket by October, when India is scheduled to host New Zealand for a Test series. For Pant, the moon boot is more than a recovery tool—it's a stepping stone towards yet another comeback. view comments Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
2 hours ago
- Time of India
Jharkhand renames Atal Mohalla Clinic after Mother Teresa, BJP calls move political appeasement
Ranchi, July 24 (IANS) The Jharkhand government has decided to rename all Atal Mohalla Clinics operating in the state as Mother Teresa Advanced Health Clinics. The decision was taken during a cabinet meeting chaired by Chief Minister Hemant Soren on Thursday. The Jharkhand cabinet's decision to rename the Atal Mohalla Clinic as the Mother Teresa Advance Health Clinic has ignited a political controversy. The BJP criticizes the move as an insult to former PM Atal Bihari Vajpayee and accuses the ruling JMM-led alliance of trying to appease Christian voters. JMM defends the renaming, emphasizing Mother Teresa's dedication to serving the poor. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads The Jharkhand cabinet on Thursday approved the renaming of the Atal Mohalla Clinic as the Mother Teresa Advance Health mohalla clinic was originally launched on August 16, 2019, by the then NDA government on the death anniversary of former PM Atal Bihari move has sparked a political slugfest between the ruling JMM-led alliance and the opposition BJP."Atal ji's unwavering resolve secured the rights of Jharkhand's people and gave tribal pride a distinct identity. But the Hemant government, stooping to the lowest level of politics, has ignored his contribution. Can it clarify how this decision will improve healthcare?" Jharkhand BJP president Babulal Marandi told added, "If the government truly wanted to honour Mother Teresa, it could have launched a new scheme in her name to serve patients, which was her life's mission. Instead, it has chosen to serve its political interests."The BJP alleged the move was aimed at wooing the state's Christian voters, seen as supporters of the JMM-led the charge, JMM leader Supriyo Bhattacharya said, "Mother Teresa is an angelic figure for the poor. Naming a health clinic for the poor in her honour is most appropriate."
Time of India
2 hours ago
- Time of India
City doctor delivers talk at top European conference
Vadodara: Dr Yash Banker, CEO of Vadodara-based Bankers Group of Hospitals, was the sole Indian speaker at the recently held HLTH Europe 2025 conference in Amsterdam. At HLTH Europe, Dr Banker delivered a talk titled "Pioneering Healthcare Entrepreneurship and Innovation in an Emerging Market". He highlighted how India's localized innovations can effectively address global healthcare challenges, emphasizing the potential for the "Indian model" of healthcare — focused on accessibility, affordability, and ingenuity — to serve as a blueprint for global healthcare delivery. "India is no longer the land of snake charmers or diseases; it has transformed into a global hub for innovation and sophisticated healthcare. Our unique solutions, born from a deep understanding of diverse needs, offer a sustainable and scalable model for global healthcare. The Indian model truly holds immense promise for worldwide application."
